Numerous studies have highlighted the critical role of the PGC1α in mitigating AKI, with growing evidence suggesting that PGC1α loss is linked to the development of renal fibrosis and chronic kidney disease (CKD) [59,60]. This evidence concerns the gene PPARGC1A and chronic kidney disease.